Informations the Corona virus and what are the new ways to avoid the virus

FDA clears Pfizer COVID19 booster vaccines for the elderly and others at high risk in three groups - those 65 years of age and older, those at high risk of developing severe COVID19, and those at risk of developing "cInformations about the Corona virus and what are the new ways to avoid the virusomplications severe "due to" frequent institutional or occupational exposure ", possibly including frontline health workers and people in prison. Clearance makes Biden administration plans to launch boosters this week at least partially possible FDA clears COVID19 Pfizer recall for high-risk adultsClick to expandUP NEXTUP NEXT "After reviewing all of the available scientific evidence and the deliberations of our independent external expert advisory board, the FDA has amended the EUA for the PfizerBioNTech COVID19 vaccine to allow a booster dose in certain populations such as healthcare workers, teachers and daycare staff, grocers and people in homeless shelters or prisons, among others, ”said FDA Commissioner Janet Woodcock in While the first two doses of the Comirnaty vaccine already have full FDA approval for use in people 16 years of age and older, the regulator has said it will now allow the third vaccination for parts of it. the US population.The Centers for Disease Control and Prevention officially recommend the third dose. This group, the CDC Advisory Committee e on Immunization Practices, met on Wednesday to discuss the potential use of Pfizer boosters. He looked at safety data collected from millions of Americans who have already received extra doses of the vaccine. breakthrough infections "and essential front-line workers like doctors and nurses, where even mild outbreaks of COVID19 can sideline fully vaccinated providers and cripple hospitals. The committee is expected to vote Thursday on its own guidelines for vaccine use.Pfizer and its German partner BioNTech had initially sought full approval of its booster doses in all adults and adolescents aged 16 and over, citing promising data from their own studies and other countries that administered third doses. . On Wednesday, the CDC unveiled new data at ACIP highlighting the decreased efficacy of the vaccine against symptomatic infection in the face of the Delta variant and potentially against severe COVID19 in the elderly. A CDC scientist also presented models suggesting that booster shots might help curb cases in nursing homes, but warned that vaccinating the elderly on its own might only have a "mild to mild effect." moderate "to curb the global spread of the pandemic. The third dose of Pfizer's vaccine has presented no safety concerns among those who have received one so far, CDC officials said. About 2.3 million Americans received an extra dose because authorities first cleared it for some people with compromised immunity. The agency also released whether actual studies suggesting the vaccine's effectiveness against infection and hospitalization have declined for many adults, although rates of COVID19 remain much higher in unvaccinated Americans. A CDC investigation into a Delta variant outbreak in a Texas federal prison was released on Tuesday. He highlighted the risk of transforming infections in crowded environments, with 70% of fully vaccinated inmates testing positive for the virus. But the FDA's vaccine consultant group expressed concern over data gaps supporting the broad need and safety for booster injections at a meeting last doctors, scientists and leading vaccine experts on our advisory board and for the important role they have played in ensuring transparent discussions on COVID19 vaccines," said Dr. Peter Marks , head of vaccines for the FDA. in a report. “The FDA has taken the committee's comments into account and conducted its own in-depth review of the data submitted to make today's decision,” Marks said. The FDA ruling only applies to people who received both doses of Pfizer's COVID19 vaccine at least six months ago. an additional dose. he halved his third dose